Safety of a paraaortic node dissection for selected advanced gastric cancer patients

Hepato-Gastroenterology

Volumn 52, Issue 65, 2005, Pages 1631-1635

  Shimoyama, Shouji ^a   Mafune, Ken Ichi ^a   Kaminishi, Michio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Advanced gastric cancer; Morbidity; Mortality; Paraaortic node dissection; Super extended lymphadenectomy

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; BLEEDING; CANCER SURVIVAL; CLINICAL ARTICLE; CYTOLOGY; EVALUATION; FEMALE; HUMAN; JAPAN; LYMPH NODE DISSECTION; MALE; MORBIDITY; NUTRITIONAL DEFICIENCY; OPERATION DURATION; OUTCOMES RESEARCH; PARAAORTIC LYMPH NODE; PATIENT SELECTION; PERITONEUM LAVAGE; PEROPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAFETY; STOMACH CANCER; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT INDICATION;

BLOOD LOSS, SURGICAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 25844500329     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJH, Dutch Gastric Cancer Group: Extended lymph node dissection for gastric cancer. N Engl J Med 1999; 340:908-914.
2. Cuschieri A, Payers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P, Surgical Cooperative Group: Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomized controlled surgical trial. Lancet 1996; 347:995-999.
3. Schmidt-Matthiesen A: Should systematic lymph node dissection be recommended for gastric cancer? Contra: Eur J Cancer 1998; 34:1483-1486.
4. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Hada M: Should systematic lymph node dissection be recommended for gastric cancer? Pro: Eur J Cancer 1998; 34:1480-1483.
5. Kasakura Y, MochizuM F, Wakabayashi K, Kochi M, Fujii M, Takayama T: An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: A retrospective study of 1403 cases at a single institution. J Surg Res 2002; 103:252-259.
6. Roukos DH, Lorenz M, Encke A: Evidence of survival benefit of extended (D2) lymphadenectomy in Western patients with gastric cancer based on a new concept. A prospective long-term follow-up study. Surgery 1998; 123:573-578.
7. Siewert JR, Bottcher K, Stein HJ, Roder JD, German Gastric Carcinoma Study Group: Relevant prognostic factors in gastric cancer. Ten year results of the German Gastric Cancer Study. Ann Surg 1998; 228:449-461.
8. Pacelli F, Doglietto GB, Bellantone R, Alfieri S, Sgadari A, Crucitti F: Extensive versus limited lymph node dissection for gastric cancer. A comparative study of 320 patients. Br J Surg 1993; 80:1153-1156.
9. Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ, German Gastric Carcinoma Study Group: Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 1993; 80:1015-1018.
10. Smith JW, Shiu MH, Kelsey L, Brennan MF: Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg 1991; 126:1469-1473.
11. Sue-Ling HM, Johnston D, Martin IG, Dixon MF, Lansdown MRJ, McMahon MJ, Axon ATR: Gastric Cancer: a curable disease in Britain. Br Med J 1993; 307:591-596.
12. Keighley MRB, Moore J, Roginski C, Powell J, Thompson H: Incidence and prognosis of N4 node involvement in gastric cancer. Br J Surg 1984; 71:863-866.
13. Adachi Y, Mimori K, Mori M, Maehara Y, Sugimachi K: Morbidity after D2 and D3 gastrectomy for node-positive gastric carcinoma. J Am Coll Surg 1997; 184:240-244.
14. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma, 2nd English Edition. Gastric Cancer 1998; 1:10-24.
15. Shimoyama S, Yasuda H, Mafune K, Katninishi M: Indications of a minimized scope of lymphadenectomy for submucosal gastric cancer. Ann Surg Oncol 2002; 9:625-631.
16. Hayes N, Ng EKW, Raimes SA, Crofts TJ, Woods SDS, Griffin SM, Chung SCC: Total gastrectomy with extended lymphadenectomy for curable stomach cancer: Experience in a non Japanese Asian center. J Am Coll Surg 1999; 188:27-32.
17. Viste A, Haùgstvedt T, Bide GE, Sereide O, The Norwegian Stomach Cancer Trial Members: Postoperative complications and mortality after surgery for gastric cancer. Ann Surg 1988; 207:7-13.
18. Wu C-W, Hsieh M-C, Lo S-S, Wang L-S, Hsu W-H, Lui W-Y, Huang M-H, P'eng F-K: Morbidity and mortality after radical gastrectomy for patients with carcinoma of the stomach. J Am Coll Surg 1995; 181:26-32.
19. Forestieri P, Formisano C, Meucci E, Mazzeo F: Total gastrectomy for gastric cancer: Reconstructive techniques, postoperative complications, and late consequences. Nutrition 1990; 6:258-260.
20. Sudo T, Ishiyama K, Takemoto M, Kawamura M, Umemura H, Shiraha S, Kuyama T, Suzuki T, Tobe T: Pancreatic endocrine function after total gastrectomy and truncal vagotomy. Am J Gastroenterol 1982; 144:539-544.
21. Nakane Y, Okamura S, Masuya Y, Okumura S, Akehira K, Hioki K: Incidence and prognosis of paraaortic lymph node metastasis in gastric cancer. Hepatogastroenterology 1998; 45:1901-1906.
22. Natsugoe S, Nakashima S, Matsumoto M, Nakajo A, Miyazono F, Kijima F, Ishigami S, Aridome I, Hokita S, Baba M, Takao S, Aikou T: Paraaortic lymph node micrometastasis and tumor cell microinvolvement in advanced gastric carcinoma. Gastric Cancer 1999; 2:179-185.
23. Siewert JR, Kestlmeier R, Busch R, Böttcher K, Roder JD, Müller J, Fellbaum C, Höfler H: Benefit of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastasis. Br J Surg 1996; 83:1144-1147.